Equa Pharma Limited in West Yorkshire, HD3 3LX

Description

Data updated on: 01-11-2023

This Equa Pharma Limited firm has been offering its services for twenty four years, having launched in 2000. Started with Registered No. 04056371, Equa Pharma is categorised as a Private Limited Company with office in 22 Holly Bank Road, West Yorkshire HD3 3LX. This company's SIC code is 74909 : Other professional, scientific and technical activities not elsewhere classified. Equa Pharma Ltd filed its latest accounts for the financial period up to January 31, 2023. The business latest annual confirmation statement was submitted on August 21, 2023.

Currently, the directors appointed by the limited company include: Christopher R. formally appointed on Sat, 8th Jun 2002 and Thomas R. formally appointed in 2000 in August. To provide support to the directors, the limited company has been using the skills of Helen R. as a secretary since August 2000.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2012-01-31	2013-01-31	2014-01-31	2015-01-31	2016-01-31	2017-01-31	2018-01-31	2019-01-31	2020-01-31	2021-01-31	2022-01-31	2023-01-31
Currency	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP
Net Worth	58 145	109 048	136 511	152 488	166 860

Balance Sheet
Cash Bank In Hand	181 922	286 070	478 183	255 996	506 376
Cash Bank On Hand					506 376	767 016	267 497	815 954	277 931	680 505	897 504	577 648
Current Assets	910 042	746 167	2 462 894	802 250	2 770 657	2 109 526	1 517 515	1 857 671	1 175 549	1 577 352	1 783 929	1 515 424
Debtors	728 120	460 097	1 984 711	546 254	2 264 281	1 342 510	1 250 018	1 041 717	897 618	896 847	886 425	937 776
Other Debtors					78 908
Property Plant Equipment					107 452	104 606	101 760	98 914	96 068	93 222
Tangible Fixed Assets	125 165	120 737	116 705	112 969	107 452

Capital & Reserves
Called Up Share Capital	100	100	100	100	100
Profit Loss Account Reserve	58 045	108 948	136 411	152 388	166 760
Shareholder Funds	58 145	109 048	136 511	152 488	166 860

Other Financial Data
Accumulated Depreciation Impairment Property Plant Equipment					39 210	42 056	44 902	47 748	50 594	53 440	4 343
Average Number Employees During Period						6	6	6	6	5	5	4
Creditors					2 711 249	2 057 619	1 467 468	1 774 495	1 061 334	1 447 937	1 563 375	1 269 643
Creditors Due Within One Year	977 062	757 856	2 443 088	762 731	2 711 249
Increase From Depreciation Charge For Year Property Plant Equipment						2 846	2 846	2 846	2 846	2 846
Net Current Assets Liabilities	-67 020	-11 689	19 806	39 519	59 408	51 907	50 047	83 176	114 215	129 415	220 554	245 781
Number Shares Allotted		100	100	100	100
Number Shares Issued Fully Paid						100	100	100	100	100	100	100
Other Creditors					4 648	6 769	5 861	6 786	5 606	5 458	5 733	6 329
Other Taxation Social Security Payable					52 921	151 263	49 479	65 519	49 380	65 915	38 523	39 735
Par Value Share		1	1	1	1	1	1	1	1	1	1	1
Property Plant Equipment Gross Cost					146 662	146 662	146 662	146 662	146 662	146 662	4 343
Share Capital Allotted Called Up Paid	100	100	100	100	100
Tangible Fixed Assets Cost Or Valuation	161 662	161 662	161 662	161 662	146 662
Tangible Fixed Assets Depreciation	36 497	40 925	44 957	48 693	39 210
Tangible Fixed Assets Depreciation Charged In Period		4 428	4 032	3 736	3 017
Tangible Fixed Assets Depreciation Decrease Increase On Disposals					12 500
Tangible Fixed Assets Disposals					15 000
Total Assets Less Current Liabilities	58 145	109 048	136 511	152 488	166 860	156 513	151 807	182 090	210 283	222 637	220 554	245 781
Trade Creditors Trade Payables					2 653 680	1 899 587	1 412 128	1 702 190	1 006 348	1 376 564	1 519 119	1 223 579
Trade Debtors Trade Receivables					2 185 373	1 342 510	1 250 018	1 041 717	897 618	896 847	823 817	892 010
Amounts Owed By Group Undertakings											62 608	45 766
Disposals Decrease In Depreciation Impairment Property Plant Equipment											49 097
Disposals Property Plant Equipment											142 319

Company staff

Christopher R.

Role: Director

Appointed: 08 June 2002

Latest update: 5 April 2024

Helen R.

Role: Secretary

Appointed: 25 August 2000

Latest update: 5 April 2024

Thomas R.

Role: Director

Appointed: 25 August 2000

Latest update: 5 April 2024

People with significant control

The companies that control this firm include: Equa Pharma Holdings Limited owns over 3/4 of company shares and has 3/4 to full of voting rights. This business can be reached in Huddersfield at Holly Bank Road, HD3 3LX and was registered as a PSC under the registration number 13111750.

Equa Pharma Holdings Limited

Address: 22 Holly Bank Road, Huddersfield, HD3 3LX, England

Legal authority Companies Act 2006

Legal form Limited Company

Country registered United Kingdom

Place registered England And Wales

Registration number 13111750

Notified on 18 August 2021

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

Thomas R.

Notified on 21 August 2016

Ceased on 18 August 2021

Nature of control:

over 1/2 to 3/4 of shares

over 1/2 to 3/4 of voting rights

Christopher R.

Notified on 21 August 2016

Ceased on 1 October 2016

Nature of control:

1/2 or less of voting rights

right to manage directors

substantial control or influence

1/2 or less of shares

Accounts Documents

Account next due date	31 October 2024
Account last made up date	31 January 2023
Confirmation statement next due date	04 September 2024
Confirmation statement last made up date	21 August 2023

Annual Accounts 17th September 2014
Start Date For Period Covered By Report	01 February 2013
End Date For Period Covered By Report	31 January 2014
Date Approval Accounts	17th September 2014
Annual Accounts 29th June 2015
Start Date For Period Covered By Report	01 February 2014
End Date For Period Covered By Report	31 January 2015
Date Approval Accounts	29th June 2015
Annual Accounts 5th October 2016
Start Date For Period Covered By Report	01 February 2015
End Date For Period Covered By Report	31 January 2016
Date Approval Accounts	5th October 2016
Annual Accounts
Start Date For Period Covered By Report	01 February 2016
End Date For Period Covered By Report	31 January 2017
Annual Accounts
Start Date For Period Covered By Report	01 February 2017
End Date For Period Covered By Report	31 January 2018
Annual Accounts
Start Date For Period Covered By Report	01 February 2018
End Date For Period Covered By Report	31 January 2019
Annual Accounts
Start Date For Period Covered By Report	01 February 2019
End Date For Period Covered By Report	31 January 2020
Annual Accounts
Start Date For Period Covered By Report	01 February 2020
End Date For Period Covered By Report	31 January 2021
Annual Accounts
Start Date For Period Covered By Report	01 February 2021
End Date For Period Covered By Report	31 January 2022
Annual Accounts
Start Date For Period Covered By Report	01 February 2022
End Date For Period Covered By Report	31 January 2023
Annual Accounts 5th August 2013
End Date For Period Covered By Report	31 January 2013
Date Approval Accounts	5th August 2013

Equa Pharma Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Christopher R.

Helen R.

Thomas R.

Secretarial Appointments Limited

Corporate Appointments Limited

People with significant control

Equa Pharma Holdings Limited

Thomas R.

Christopher R.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies